DCM
TPTX
DAFNA Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-48,452
| Closed | -$3.65M | – | 95 |
|
|
2022
Q2 | $3.65M | Sell |
48,452
-11,000
| -19% | -$828K | 0.99% | 32 |
|
|
2022
Q1 | $1.6M | Buy |
59,452
+13,000
| +28% | +$349K | 0.42% | 60 |
|
|
2021
Q4 | $2.22M | Buy |
46,452
+4,500
| +11% | +$215K | 0.56% | 40 |
|
|
2021
Q3 | $2.79M | Sell |
41,952
-5,900
| -12% | -$392K | 0.74% | 36 |
|
|
2021
Q2 | $3.73M | Buy |
47,852
+37,343
| +355% | +$2.91M | 0.78% | 32 |
|
|
2021
Q1 | $994K | Buy |
+10,509
| New | +$994K | 0.24% | 71 |
|
|
2020
Q3 | – | Sell |
-23,210
| Closed | -$1.5M | – | 96 |
|
|
2020
Q2 | $1.5M | Sell |
23,210
-23,698
| -51% | -$1.53M | 0.43% | 45 |
|
|
2020
Q1 | $2.1M | Buy |
46,908
+16,500
| +54% | +$737K | 0.87% | 33 |
|
|
2019
Q4 | $1.89M | Sell |
30,408
-16,900
| -36% | -$1.05M | 0.65% | 34 |
|
|
2019
Q3 | $1.78M | Buy |
+47,308
| New | +$1.78M | 0.67% | 39 |
|